Clinical Trial Update: Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing ferric maltol oral suspension with ferrous sulfate oral liquid in children and adolescents with iron-deficiency anemia (with a single-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia

Drugs mentioned

• Ferric Maltol (ferric maltol)
• Ferrous sulfate (ferrous sulfate)

Snippet

Sponsor: Shield Therapeutics | Conditions: Anemia, Iron-deficiency | Phase 3 | Status: COMPLETED | Results posted: 2025-11-10